Dietary macronutrient substrates

Dietary macronutrient substrates, comprising proteins, lipids, and carbohydrates, are the primary targets for exogenous digestive enzyme replacement therapy (PERT). In healthy physiology, these complex molecules are hydrolyzed by endogenous enzymes—such as amylase, lipase, and proteases—into smaller units like simple sugars, fatty acids, and amino acids that can be absorbed by the intestinal mucosa (StatPearls, 2023). However, in conditions such as exocrine pancreatic insufficiency (EPI), which is frequently associated with cystic fibrosis, chronic pancreatitis, or pancreatic cancer, the body fails to produce or secrete adequate levels of these enzymes (NIH, 2022). This deficiency leads to malabsorption, steatorrhea, and significant nutritional deficiencies. Exogenous digestive enzymes, typically formulated as pancrelipase from porcine sources, are administered orally to facilitate the breakdown of these dietary substrates within the duodenum (Mayo Clinic, 2023). By restoring the digestive capacity, these enzymes allow for the absorption of essential nutrients, thereby improving weight maintenance and overall clinical outcomes in patients with impaired pancreatic function (Cystic Fibrosis Foundation, 2023).

Other names

Dietary proteinsDietary lipidsDietary carbohydratesMacronutrientsEnzyme substrates

Exogenous digestive enzymes catalyze the hydrolytic cleavage of dietary proteins, fats, and carbohydrates into smaller, absorbable molecular units within the lumen of the gastrointestinal tract (StatPearls, 2023).